— Remdesivir analogue demonstrates non-inferiority, good safety in Chinese randomized trial by Ingrid Hein, published in MedPage Today on January 3, 2023 An oral remdesivir analogue (VV116) was just as good as nirmatrelvir-ritonavir (Paxlovid) for the...
— "Infuriating to see misinformation mongers being taken seriously" by Amanda D'Ambrosio Pierre Kory, MD, one of the most vocal proponents of ivermectin for COVID-19, has the support of Simon & Schuster, with the leading publishing house slated to distribute his...
— As the U.S. heads back to "normal," we should never return to the old way health systems were run by Gary Tamkin, MD "Never let a good crisis go to waste." -- Winston Churchill Many of the initiatives adopted by hospitals, regulatory agencies, executives, and care...
— We must regulate LDTs that carry risk by Stephanie Rogus, PhD, RDN, and Peter G. Lurie, MD, MPH Imagine nearly ending a pregnancy because a lab test was wrong. In January 2022, a story in the New York Times recounted one pregnant woman's...
— This past week in healthcare investigations by Jennifer Henderson Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. News Outlets Stand By Story on COVID Origin...
— No, but a recent study has been misinterpreted by some as saying that by Jeremy Faust, MD What happens to people who get reinfected with SARS-CoV-2, the virus that causes COVID-19? A recent paper in Nature Medicine has...
— 58% of infectious diseases aggravated by climatic hazards at some point, says Camilo Mora by Emily Hutto At the beginning of the COVID pandemic, obviously there was a huge interest in whether this disease was being caused or was caused by climate change. So we...
— What will a new generation of variant-targeting and infection-preventing vaccines look like? by John P. Moore, PhD, and E. John Wherry, PhD America's COVID-19 vaccine booster policy remains confusing. We are regularly asked by members of the public, friends, and...
— Researchers say new analyses point to Wuhan market as early epicenter by Jennifer Henderson Two complementary studies published in Science provide the latest evidence against the idea that COVID-19 leaked from a Chinese lab, and instead point to the Huanan...
— This past week in healthcare investigations by Kristina Fiore The Nonprofit at the Center of the COVID Origin Debate Vanity Fair's Katherine Eban details the evolution of the EcoHealth Alliance, the American non-profit with extensive ties to the Wuhan Institute...
— Kristina Lawson depicted as Nazi: "It is disturbing to be targeted by anti-science zealots" by Cheryl Clark Kristina Lawson, president of the California Medical Board, is again publicly fighting back against the controversial group America's Frontline Doctors and...
— Statistician alleges data in study led by Paul Marik, MD, were fabricated by Kristina Fiore The data underpinning an infamous study of vitamin C for sepsis may be fraudulent, according to an analysis by an Australian physician and...
— Results more favorable for older people, those with comorbidities by Nicole Lou People with moderate COVID-19 illness tended to have better clinical outcomes if they took aspirin their first day in the hospital, according to data from the NIH's National COVID Cohort...
— Cognitive tests show "notable reduction" in memory ability by Judy George Seven in 10 people, most of whom said they had long COVID, experienced concentration and memory problems months after acute SARS-CoV-2 infection and many performed worse than their peers on...
— Gregory Poland, MD, advocates both vaccination and better understanding of possible side effect by Jennifer Henderson Gregory Poland, MD, director of the Mayo Clinic's Vaccine Research Group in Rochester, Minnesota, remains a steadfast vaccination advocate -- even...